ES2068800T1 - Preparacion farmaceutica en forma de un comprimido efervescente o de desintegracion o un granulado soluble al instante, y procedimiento para su produccion. - Google Patents
Preparacion farmaceutica en forma de un comprimido efervescente o de desintegracion o un granulado soluble al instante, y procedimiento para su produccion.Info
- Publication number
- ES2068800T1 ES2068800T1 ES93902180T ES93902180T ES2068800T1 ES 2068800 T1 ES2068800 T1 ES 2068800T1 ES 93902180 T ES93902180 T ES 93902180T ES 93902180 T ES93902180 T ES 93902180T ES 2068800 T1 ES2068800 T1 ES 2068800T1
- Authority
- ES
- Spain
- Prior art keywords
- agent
- preference
- matrix
- effervescent
- pharmaceutical preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008187 granular material Substances 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 7
- 239000011159 matrix material Substances 0.000 abstract 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000003792 electrolyte Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 238000005469 granulation Methods 0.000 abstract 1
- 239000002973 irritant agent Substances 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920000193 polymethacrylate Polymers 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
LA PREPARACION FARMACEUTICA EN LA FORMA DE UNA TABLETA EFERVESCENTE Y/O DESINTEGRABLE O EN UN GRANULADO INSTANTANEO CONTIENE AL MENOS UN AGENTE IRRITANTE PARA EL GUSTO Y AL MENOS UNA MATRIZ DE RETRASO DE LIBERACION DEL AGENTE QUE ESTA UNIDO INTIMAMENTE CON LAS PARTICULAS DEL AGENTE O BIEN LAS ENVUELVE Y LAS APLICA A UN SUBSTRATO. LA PREPARACION EN SOLUCION ACUOSA A TEMPERATURA AMBIENTE LIBERA COMO MAXIMO 65 Y CON PREFERENCIA 50 % DEL AGENTE DENTRO DE APROXIMADAMENTE 2 MINUTOS, PERO EN 0,1 N HCI A 38 % DEL AGENTE EN UN TIEMPO COMO MAXIMO DE 20 Y CON PREFERENCIA DE 15 MINUTOS. LA MATRIZ CONTIENE PREFERENTEMENTE AL MENOS UN ESTER DE ACIDO GRASO Y/O UNA CERA, CON PREFERENCIA CON UN PUNTO DE FUSION ENTRE 30 Y 45, ESPECIALMENTE ENTRE 32 Y 35 MENOS UN DERIVADOS DE CELULOSA Y/O Y AL MENOS UN ESTER ACIDO POLIMETACRILATO. LA CANTIDAD DEL AGENTE SE ENCUENTRA POR DEBAJO DE 60 Y CON PREFERENCIA POR DEBAJO DE 10 MG, DE FORMA QUE EN LA MATRIZ SE DISPONE DE 1 HASTA 10, CON PREFERENCIA 3 HASTA 5 VECES DE LACANTIDAD CORRESPONDIENTE AL AGENTE POR TABLETA O DOSIS DE GRANULADO. PARA EL TRATAMIENTO DE DIARREA MEDIANTE AL MENOS LIPERAMIDA, LA MATRIZ CONTIENE TAMBIEN UNA MEZCLA Y CANTIDAD DE SALES ALCALINAS Y/O ALCALINOTERREAS, CON PREFERENCIA SALES ORGANICAS Y CLORUROS QUE COMPENSAN LA PERDIDA DE ELECTROLITOS EN EL CUERPO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92100441 | 1992-01-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2068800T1 true ES2068800T1 (es) | 1995-05-01 |
| ES2068800T3 ES2068800T3 (es) | 1995-12-16 |
Family
ID=8209237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES93902180T Expired - Lifetime ES2068800T3 (es) | 1992-01-13 | 1993-01-12 | Preparacion farmaceutica en forma de un comprimido efervescente y/o de descomposicion, o de un granulado instantaneo, asi como procedimiento para su fabricacion. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5587179A (es) |
| EP (1) | EP0620731B1 (es) |
| JP (1) | JPH07506336A (es) |
| AT (1) | ATE128028T1 (es) |
| AU (1) | AU668375B2 (es) |
| CA (1) | CA2127352C (es) |
| CZ (1) | CZ283351B6 (es) |
| DE (1) | DE59300632D1 (es) |
| DK (1) | DK0620731T3 (es) |
| ES (1) | ES2068800T3 (es) |
| FI (1) | FI110353B (es) |
| GR (2) | GR950300005T1 (es) |
| MX (1) | MX9300110A (es) |
| PL (1) | PL173676B1 (es) |
| WO (1) | WO1993013760A1 (es) |
| ZA (1) | ZA93215B (es) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5395627A (en) * | 1992-09-04 | 1995-03-07 | Akzo N.V. | Pharmaceutical granulate |
| DE4403943A1 (de) * | 1994-02-08 | 1995-08-10 | Hexal Pharma Gmbh | Orale Azrneimittelzubereitung mit Diclofenac-Natrium |
| TW466119B (en) * | 1994-02-28 | 2001-12-01 | Janssen Pharmaceutica Nv | Film coated tablet of paracetamol and domperidone |
| US5837287A (en) * | 1994-10-28 | 1998-11-17 | R P Scherer Corporation | Process for preparing solid pharmaceutical dosage forms |
| GB9421836D0 (en) * | 1994-10-28 | 1994-12-14 | Scherer Corp R P | Process for preparing solid pharmaceutical dosage forms of hydrophobic substances |
| US5807577A (en) * | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
| US6974595B1 (en) * | 1996-05-17 | 2005-12-13 | Proethic Pharmaceuticals, Inc. | Pharmaceutical compositions based on Diclofenae |
| GB9710767D0 (en) * | 1996-06-26 | 1997-07-23 | On Ninh | Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same |
| BE1011045A3 (fr) * | 1997-03-14 | 1999-04-06 | Ucb Sa | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
| US5843477A (en) * | 1997-09-30 | 1998-12-01 | Bayer Corporation | Lubricants for use in tabletting |
| US5904937A (en) * | 1997-10-03 | 1999-05-18 | Fmc Corporation | Taste masked pharmaceutical compositions |
| DE19814257A1 (de) * | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Brauseformulierungen |
| DE19814256A1 (de) * | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Feste, schnellzerfallende Cetirizin-Formulierungen |
| DE19822036A1 (de) * | 1998-05-15 | 1999-11-18 | Bayer Ag | Brausezubereitungen |
| GB9816899D0 (en) | 1998-08-05 | 1998-09-30 | Boots Co Plc | Therapeutic agents |
| US7001612B2 (en) | 1998-08-26 | 2006-02-21 | All Sun Hsf Company Limited | Composition for the relief of heat stress |
| US6235322B1 (en) * | 1999-03-09 | 2001-05-22 | Mintech, Inc. | Highly soluble and stable mineral supplements containing calcium and magnesium |
| US6284270B1 (en) | 1999-08-04 | 2001-09-04 | Drugtech Corporation | Means for creating a mass having structural integrity |
| WO2001010405A1 (en) * | 1999-08-04 | 2001-02-15 | Ranbaxy Laboratories Limited | Hydrodynamically balanced oral drug delivery system |
| BR0108730A (pt) * | 2000-02-28 | 2002-11-05 | Vectura Ltd | Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados |
| AU2001275043A1 (en) | 2000-05-31 | 2001-12-11 | Drugtech Corporation | Mineral supplement |
| GB0222612D0 (en) * | 2002-09-30 | 2002-11-06 | Univ Gent | Controlled delivery system for bioactive substances |
| JP2006506362A (ja) * | 2002-10-11 | 2006-02-23 | デポメド・ディベロップメント・リミテッド | 胃内保持型レボドパデリバリー形態 |
| JP4601271B2 (ja) * | 2003-08-01 | 2010-12-22 | 大洋薬品工業株式会社 | 圧縮成形製剤およびその製造方法 |
| WO2005021056A1 (en) * | 2003-08-21 | 2005-03-10 | Cns, Inc. | Effervescent delivery system |
| US7491263B2 (en) | 2004-04-05 | 2009-02-17 | Technology Innovation, Llc | Storage assembly |
| US8216610B2 (en) * | 2004-05-28 | 2012-07-10 | Imaginot Pty Ltd. | Oral paracetamol formulations |
| JO3352B1 (ar) * | 2005-06-17 | 2019-03-13 | Apr Applied Pharma Res Sa | صيغ دايكلوفيناك وطرق استخدامه |
| US7811604B1 (en) | 2005-11-14 | 2010-10-12 | Barr Laboratories, Inc. | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same |
| CA2629904C (en) | 2005-11-28 | 2018-07-10 | Imaginot Pty Ltd. | Oral therapeutic compound delivery system |
| EP1902708A1 (de) | 2006-09-25 | 2008-03-26 | Losan Pharma GmbH | Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung |
| CN101084881B (zh) * | 2007-06-23 | 2012-08-29 | 淮北辉克药业有限公司 | 靶向速释泡腾制剂及其制备方法 |
| KR101560176B1 (ko) * | 2007-10-31 | 2015-10-14 | 맥네일-피피씨, 인코포레이티드 | 구강내 붕해성 투여 형태 |
| US8343533B2 (en) | 2009-09-24 | 2013-01-01 | Mcneil-Ppc, Inc. | Manufacture of lozenge product with radiofrequency |
| US8858210B2 (en) | 2009-09-24 | 2014-10-14 | Mcneil-Ppc, Inc. | Manufacture of variable density dosage forms utilizing radiofrequency energy |
| US8313768B2 (en) | 2009-09-24 | 2012-11-20 | Mcneil-Ppc, Inc. | Manufacture of tablet having immediate release region and sustained release region |
| US9445971B2 (en) | 2012-05-01 | 2016-09-20 | Johnson & Johnson Consumer Inc. | Method of manufacturing solid dosage form |
| US9511028B2 (en) | 2012-05-01 | 2016-12-06 | Johnson & Johnson Consumer Inc. | Orally disintegrating tablet |
| PT2953617T (pt) | 2013-02-06 | 2020-01-14 | Hermes Arzneimittel Gmbh | Composições farmacêuticas que incorporam fármacos de baixa dose |
| US9789066B2 (en) | 2014-01-10 | 2017-10-17 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
| PL3157506T3 (pl) | 2014-06-20 | 2021-03-08 | Hermes Arzneimittel Gmbh | Kompozycja farmaceutyczna do podawania doustnego o maskowanym smaku |
| US10493026B2 (en) | 2017-03-20 | 2019-12-03 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4289751A (en) * | 1979-06-29 | 1981-09-15 | Merck & Co., Inc. | Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof |
| US4704284A (en) * | 1982-08-12 | 1987-11-03 | Pfizer Inc. | Long-acting matrix tablet formulations |
| US4539198A (en) * | 1983-07-07 | 1985-09-03 | Rowell Laboratories, Inc. | Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range |
| NL194389C (nl) * | 1984-06-14 | 2002-03-04 | Novartis Ag | Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager. |
| DE3440288C2 (de) * | 1984-11-05 | 1987-03-12 | Gergely, Gerhard, Dr.-Ing., Wien | Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung |
| DE3524003A1 (de) * | 1985-07-04 | 1987-01-08 | Heumann Ludwig & Co Gmbh | Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung |
| JPH0830005B2 (ja) * | 1985-09-25 | 1996-03-27 | ゲルゲリイ、ゲルハルト | 崩壊性錠剤とその製造方法 |
| US4753800A (en) * | 1985-10-04 | 1988-06-28 | Warner-Lambert Company | Medicament adsorbates and their preparation |
| NZ231281A (en) * | 1988-11-08 | 1991-01-29 | Takeda Chemical Industries Ltd | Sustained release pharmaceutical preparations comprising the active agent dispersed in a solid matrix of a fatty acid ester of a polyglycerol |
| GB8908361D0 (en) * | 1989-04-13 | 1989-06-01 | Beecham Group Plc | Composition |
-
1993
- 1993-01-11 MX MX9300110A patent/MX9300110A/es not_active IP Right Cessation
- 1993-01-12 ES ES93902180T patent/ES2068800T3/es not_active Expired - Lifetime
- 1993-01-12 CA CA002127352A patent/CA2127352C/en not_active Expired - Fee Related
- 1993-01-12 PL PL93304677A patent/PL173676B1/pl not_active IP Right Cessation
- 1993-01-12 WO PCT/EP1993/000055 patent/WO1993013760A1/de not_active Ceased
- 1993-01-12 US US08/256,503 patent/US5587179A/en not_active Expired - Lifetime
- 1993-01-12 DK DK93902180.4T patent/DK0620731T3/da active
- 1993-01-12 CZ CZ941605A patent/CZ283351B6/cs not_active IP Right Cessation
- 1993-01-12 AU AU33492/93A patent/AU668375B2/en not_active Ceased
- 1993-01-12 JP JP5512137A patent/JPH07506336A/ja active Pending
- 1993-01-12 AT AT93902180T patent/ATE128028T1/de active
- 1993-01-12 DE DE59300632T patent/DE59300632D1/de not_active Expired - Lifetime
- 1993-01-12 EP EP93902180A patent/EP0620731B1/de not_active Expired - Lifetime
- 1993-01-13 ZA ZA93215A patent/ZA93215B/xx unknown
-
1994
- 1994-07-12 FI FI943315A patent/FI110353B/fi active
-
1995
- 1995-02-28 GR GR950300005T patent/GR950300005T1/el unknown
- 1995-10-18 GR GR950402909T patent/GR3017806T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR950300005T1 (en) | 1995-02-28 |
| FI110353B (fi) | 2002-12-31 |
| CA2127352C (en) | 2005-05-31 |
| DK0620731T3 (da) | 1996-04-09 |
| FI943315A7 (fi) | 1994-07-12 |
| ES2068800T3 (es) | 1995-12-16 |
| CZ283351B6 (cs) | 1998-03-18 |
| ATE128028T1 (de) | 1995-10-15 |
| ZA93215B (en) | 1993-08-19 |
| AU3349293A (en) | 1993-08-03 |
| PL173676B1 (pl) | 1998-04-30 |
| EP0620731A1 (de) | 1994-10-26 |
| JPH07506336A (ja) | 1995-07-13 |
| CA2127352A1 (en) | 1993-07-22 |
| DE59300632D1 (de) | 1995-10-26 |
| EP0620731B1 (de) | 1995-09-20 |
| AU668375B2 (en) | 1996-05-02 |
| CZ160594A3 (en) | 1994-12-15 |
| MX9300110A (es) | 1994-07-29 |
| FI943315A0 (fi) | 1994-07-12 |
| US5587179A (en) | 1996-12-24 |
| GR3017806T3 (en) | 1996-01-31 |
| WO1993013760A1 (de) | 1993-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2068800T3 (es) | Preparacion farmaceutica en forma de un comprimido efervescente y/o de descomposicion, o de un granulado instantaneo, asi como procedimiento para su fabricacion. | |
| ES2167453T3 (es) | Composicion de suministro medicamentoso que contiene quitosano o derivado del mismo con un potencial z. definido. | |
| US5279673A (en) | Methods to disinfect contact lenses | |
| NO305931B1 (no) | Fremgangsmåte for fremstilling av en blanding for kontrollert avgivelse av biologisk aktive midler | |
| CO4960646A1 (es) | Tabletas de metilcelulosa rapidamente desintegrables | |
| ES2145118T3 (es) | Derivados de acidos grasos y composiciones farmaceuticas que los contienen. | |
| ES2185758T3 (es) | Utilizacion de esteres grasos etoxilados como compuestos auto-emulsionables. | |
| ES2141775T3 (es) | Composicion medicinal a base de agua termicamente gelificante reversible. | |
| AU2003304237A1 (en) | Gel-stabilized nanoparticulate active agent compositions | |
| UA26455C2 (uk) | Лікарський препарат у формі таблеток із сповільhеhим вивільhеhhям активhого іhгредієhта | |
| NZ541593A (en) | Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis | |
| ES2155473T3 (es) | Composicion veterinaria que contiene un inhibidor de las bombas de protones. | |
| ES2058362T3 (es) | Tableta de limpieza para protesis dentales. | |
| PL334348A1 (en) | Method of treating prostate diseases using vitamin d formulations of retarded and/or prolonged release | |
| CO4960651A1 (es) | Tabletas de metilcelulosa rapidamente desintegrables | |
| MXPA03006364A (es) | TRATAMIENTO DE PERTURBACIONES DEL SUEnO. | |
| BG106602A (en) | Formulation of substituted benzimidazoles | |
| PE20030323A1 (es) | Composicion farmaceutica | |
| US5152912A (en) | Chlorine dioxide precursor containing compositions useful in disinfecting contact lenses | |
| ES2202831T3 (es) | Composiciones que destruyen el peroxido de hidrogeno y metodos de utilizacion. | |
| CO5540295A2 (es) | Comprimido para tragar que comprende paracetamol | |
| JP2004537546A5 (es) | ||
| ES2875624T3 (es) | Formulación gelificante a base de gluconato de calcio | |
| Goodman | Managing acne vulgaris effectively | |
| DK1255535T3 (da) | Lægemiddelsammensætning med kontrolleret frisætning indeholdende tramadol-hydrochlorid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 620731 Country of ref document: ES |